Cargando…
Treatment of Chronic Hepatitis C in the Aged – Does It Impact Life Expectancy? A Decision Analysis
BACKGROUND AND AIMS: Recent studies have demonstrated that the efficacy of interferon-free direct-acting antiviral agents (DAAs) in patients over 70 is similar to that of younger age groups. Evidence continues to mount that life expectancy (LE) increases with successful treatment of hepatitis C (HCV...
Autores principales: | Maor, Yaakov, Malnick, Stephen D. H., Melzer, Ehud, Leshno, Moshe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943667/ https://www.ncbi.nlm.nih.gov/pubmed/27410963 http://dx.doi.org/10.1371/journal.pone.0157832 |
Ejemplares similares
-
Liraglutide-Induced Hepatotoxicity
por: Maor, Yaakov, et al.
Publicado: (2021) -
Alcoholic Liver Disease: Role of Cytokines
por: Neuman, Manuela G., et al.
Publicado: (2015) -
Liver Injury Induced by Anticancer Chemotherapy and Radiation Therapy
por: Maor, Y., et al.
Publicado: (2013) -
Does pain deteriorate working life expectancy in aging workers?
por: Lee, Wanhyung, et al.
Publicado: (2016) -
Life expectancy: what does it measure?
por: Modig, Karin, et al.
Publicado: (2020)